companydata.dkcompanydata.dk

ABL BIOTEC A/S: Financial statements 2023

CVR: 50811018

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -133,057 and a net result of DKK 3,651,613 compared with DKK -2,875,355 the year before. Equity in the 2023 report amounted to DKK 28,896,888. The solvency ratio was 99.3%. The company had 1 employee in the financial year.

Gross Profit
DKK -133,057
Profit/Loss
DKK 3,651,613
Equity
DKK 28,896,888
Total Assets
DKK 29,092,872
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--133 t.3.7 mio.28.9 mio.1
2022--156 t.-2.9 mio.26.3 mio.1
2021--130 t.3.7 mio.29.8 mio.1
2020--116 t.2.5 mio.26.6 mio.1
2019--114 t.3.3 mio.24.7 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Kirsten Bach-Larsen joins the board of ABL BIOTEC A/SSep 14, 2023

As of September 14, 2023, Kirsten Bach-Larsen has joined the board of directors of ABL BIOTEC A/S.

Gitte Larsen joins the board of ABL BIOTEC A/SSep 14, 2023

As of September 14, 2023, Gitte Larsen has joined the board of directors of ABL BIOTEC A/S.

Rikke Dahl Andersson joins the board of ABL BIOTEC A/SSep 14, 2023

As of September 14, 2023, Rikke Dahl Andersson has joined the board of directors of ABL BIOTEC A/S.

Asger Bach-Larsen joins ABL BIOTEC A/S as adm. dir.Sep 14, 2023

As of September 14, 2023, Asger Bach-Larsen is registered as adm. dir. of ABL BIOTEC A/S.

Asger Bach-Larsen leaves the board of ABL BIOTEC A/SSep 4, 2023

As of September 4, 2023, Asger Bach-Larsen has left the board of directors of ABL BIOTEC A/S.

Kirsten Bach-Larsen leaves the board of ABL BIOTEC A/SSep 4, 2023

As of September 4, 2023, Kirsten Bach-Larsen has left the board of directors of ABL BIOTEC A/S.

Gitte Larsen leaves the board of ABL BIOTEC A/SSep 4, 2023

As of September 4, 2023, Gitte Larsen has left the board of directors of ABL BIOTEC A/S.

Rikke Dahl Andersson leaves the board of ABL BIOTEC A/SSep 4, 2023

As of September 4, 2023, Rikke Dahl Andersson has left the board of directors of ABL BIOTEC A/S.

Asger Bach-Larsen steps down as director of ABL BIOTEC A/SSep 4, 2023

As of September 4, 2023, Asger Bach-Larsen has stepped down as director of ABL BIOTEC A/S.

ABL BIOTEC A/S: The 2022 annual report is outApr 4, 2023

ABL BIOTEC A/S has published its annual report for 2022. Gross profit came to DKK -156,457, and the net result was DKK -2,875,355.

About ABL BIOTEC A/S

ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named KONTORBUTIKKEN ApS and PAPIR EN GROS VIGGO TRANHOLM MADSEN ApS. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.

Source: annual report 2025, Danish Business Authority